According to the new market research report by Industry ARC titled “Vaccines Market: By Type, By Technology, By Disease Indication, By End User, and By Geography Analysis - Forecast (2018-2023),” the market is driven by the new technological advancements and collaboration strategies adopted by key players globally.
The Inactivated Vaccines segment holds the major share in the Global Vaccines Market
The Inactivated Vaccines segment dominated the market with a large market share. Researchers and market players invest in R&D to develop safe and effective vaccines, and introduce new inactivated vaccines after clinical studies have been completed, thus boosting the growth of the inactivated vaccines market. The increasing prevalence of various viral and bacterial diseases around the world has increased demand for inactivated vaccines, which in turn is fuelling the growth of the market. Inactivated Vaccines Market is projected to grow at a CAGR of 8.96% during the forecast period.
Selected/Sample Analysis done in full report
By Disease, Human Papilloma Virus (HPV) has witnessed significant growth due to the fact that it is the most common sexually transmitted infection in the U.S. Due to human papillomavirus infection, more than 60% of penile cancers, 70% of vulvar and vaginal cancers, and 90% of anal and cervical cancers are caused. As per a report by the Centers for Disease Control and Prevention (CDC 14 million new cases of human papillomavirus are recorded in the U.S. each year.
By End User, the Pediatrics segment is witnessing growth because of increased incidence of infant diseases such as chicken pox, typhoid, cholera, measles, and hepatitis.
Talk to one of our sales representatives about the full report by providing your details in the link below:
Excerpts on Market Growth Factors
- Based on diseases, Human Papilloma Virus market share is expected to grow due to the rising incidence of various chronic disease.
- A few key players, such as GSK, are focusing on building strong, competitive pipeline of consumer-led, science-based innovations in the field of vaccines.
- The rising company initiatives to enhance R&D in vaccines and the growing government support for vaccine development are projected to accelerate the growth of the global vaccines market in the next few years.
To request for a quote, click the link below:
Key players of the Global Vaccines Market
Pfizer Inc., a New York based company that operates in more than 60 countries, offers various types of product such as Prevnar 13/Prevenar 13, Nimenrix, Trumenba, and Others. The major competitors in this market are GlacoSmithKline, Merck and Co, Sanofi Genzyme, and many more.
The Global Vaccines Market is segmented as below:
A. Global Vaccines Market -- By Technology
1. Live Attenuated Vaccines
2. Inactive and Subunit Vaccines
3. Toxoid Vaccines
4. Conjugate Vaccines
5. Recombinant Vaccines
B. Global Vaccines Market -- By Disease Indication
1. Pneumococcal Disease
4. Human Papilloma Virus
5. Meningococcal Disease
C. Global Vaccines Market -- By End User
D. Global Vaccines Market -- By Geography
1. North America
2.6 Rest of Europe
3.4 South Korea
3.6 Rest of APAC
4. Rest of World (RoW)
4.1 South America
4.2 Middle East
E. Global Vaccines Market -- Market Entropy
F. Companies cited/Interviewed
1. GlacoSmithKline plc
2. Merck & Co.
3. Sanofi Pasteur
4. Pfizer Inc.
5. Serum Institute of India Private Ltd.
6. CSL Limited
7. Emergent Biosolutions
8. AstraZeneca Plc.
9. Mitsubishi Tanabe Pharma Corporation
10. Astellas Pharma Inc.
1. Veterinary Vaccines Market
2. Medical Robotics Market
IndustryARC is a research and consulting firm that publishes more than 500 reports annually in various industries, such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences & Healthcare.
IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business.
We look forward to supporting the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today.
Mr. Venkateshwar Reddy
Business Development Manager
Email: [email protected]
Contact Sales: 1-614-588-8538 (Ext-101)
Connect with us on LinkedIn - https://www.linkedin.com/company/industryarc